đ€
Gileadâs Covid-19 drug remdesivir will be priced at $3,120 for a typical U.S. patient with commercial insurance.
Gilead Sciences Inc. detailed its pricing plans for Covid-19 drug remdesivir, saying it will charge U.S. hospitals $3,120 for a typical patient with commercial insurance.
However, the situation has been improving as Chinese tech giants including e-commerce company Alibaba, search engine Baidu, on-demand delivery company Meituan Dianping, ride-hailing operator Didi Chuxing and smartphone maker Xiaomi now offer more affordable health care plans via mutual aid platforms, which operate as a collective claim-sharing mechanism.
Chinaâs online mutual aid platforms are disrupting old school insurance companies by leveraging big data and internet finance technologies to offer low cost medical coverage.
With perspectives and passions, Millennial and Generation Z entrepreneurs are at the forefront of AI innovation. They are unlocking new ways to do even the mundane tasks and will forever change how we work and look at the world.
Conversation and human language is a particularly challenging area for computers, since words and communication is not precise. Learn more about the conversational pattern of AI.
Physicists from the University of Glasgow and the University of Arizona have experimentally verified a half-century-old theory that began as speculation about how an advanced alien civilization could use a rotating black hole to generate energy.
Pluto is thought to possess a subsurface ocean beneath its thick ice shell. It has generally been assumed that the dwarf planet formed out of cold material and then later developed its ocean due to warming from radioactive decay. By combining numerical simulations with geological observations by NASAâs New Horizons mission, a team of researchers from the University of California Santa Cruz and the Southwest Research Institute demonstrated that Pluto was instead relatively hot when it formed, with an early subsurface ocean.
Canada is marching forward with its international partners to establish a permanent research installation near the Moon, the Lunar Gateway.
As it did for the Shuttle and Station programs before, the Canadian Space Agency, via a partnership with MacDonald, Dettwiler, and Associates, Inc., will build the next-generation robotic system: Canadarm3.
Continue reading “Canadarm3 to support Lunar Gateway space station” »
Animal experiments demonstrating the anti-aging effects of exchanging young blood plasma for old have been prominent in the last two months. Several groups are saying itâs time to translate their findings into human trials. But Iâve recently learned that others have been doing this for several years. What can we learn from their results to guide the next steps in experimentation?
I had never heard of Grifols, the Spanish pharmaceutical company that is the worldâs largest supplier of albumin. Since 2005, Grifols has been quietly funding world leaders in plasma exchange research in humans. Albutein Âź is their brand-name solution of human albumin.
Last month, the first results of the Grifolâs AMBAR trial were released. (AMBAR stands for A lzheimerâs M odulation B y A lbumin R eplacement). It was a much larger-scale phase 2.5 trial, with 496 subjects recruited from sites in Spain and USA, and treated for 14 months. A single treatment consisted of removing 2.5 to 3 litres of blood (more than half the bodyâs inventory) and replacing it with Albutein. Patients began with 6 weekly treatments, and thereafter there were 12 monthly smaller plasma replacements (0.7 litres), again with Albutein.
Last yearâs Netflix movie The Great Hack detailed the dark side of data collection, centered around the 2016 Cambridge Analytica scandal. The movie describes how âpsychometric profilesâ exist for you, me, and all of our friends. The data collected from our use of digital services can be packaged in a way that gives companies insight into our habits, preferences, and even our personalities. With this information, they can do anything from show us an ad for a pair of shoes weâll probably like to try to change our minds about which candidate to vote for in an election.
With so much of our data already out there, plus the fact that most of us will likely keep using the free apps weâve enjoyed for years, could it be too late to try to fundamentally change the way this model works?
Continue reading “Your Personal Data Is Worth Money. Andrew Yang Wants to Get You Paid” »
